First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

New England Journal of Medicine, Volume 376, Issue 25, Page 2415-2426, June 2017.


from α1 via xlomafota.13 on Inoreader http://ift.tt/2rU8Hmk
via IFTTT